Verrica Pharmaceuticals Interest Expense | VRCA

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Verrica Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-3 K	-17 K	3.96 M	2.17 M	4.3 M	3.03 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
4.3 M	-17 K	2.24 M

Quarterly Interest Expense Verrica Pharmaceuticals

2026-Q2	2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-3 K	-8 K	-	-1 K	-	-	-1 K	-5 K	-11 K	-	1.66 M	-	-	-	81 K	1.07 M	1.08 M	-	1.09 M	1.08 M	1.03 M	-	918 K	904 K	220 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.66 M	-11 K	568 K

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Brickell Biotech BBI	5 K	-	-5.38 %	$ 6.06 M	USA
Applied Therapeutics APLT	-77 K	-	-	$ 8.42 M	USA
Merus N.V. MRUS	1.06 M	-	-	$ 5.78 B	Niderland
Exicure XCUR	-275 K	$ 1.09	3.81 %	$ 6.86 M	USA
Cellectis S.A. CLLS	371 K	$ 0.95	-3.3 %	$ 95.3 M	France
AbCellera Biologics ABCL	-2.71 M	$ 12.03	1.78 %	$ 3.59 B	Canada
Arrowhead Pharmaceuticals ARWR	5.26 M	$ 58.93	1.57 %	$ 7.88 B	USA
BioMarin Pharmaceutical BMRN	17.3 M	$ 55.62	-0.59 %	$ 10.7 B	USA
Celldex Therapeutics CLDX	927 K	$ 29.48	0.79 %	$ 1.96 B	USA
Jaguar Health JAGX	67 K	$ 2.36	15.44 %	$ 5.5 M	USA
Protalix BioTherapeutics PLX	3.55 M	$ 2.49	-2.35 %	$ 196 M	Israel
uniQure N.V. QURE	10.9 M	$ 21.65	-3.5 %	$ 1.24 B	Niderland
Stoke Therapeutics STOK	9 K	$ 25.41	1.48 %	$ 1.5 B	USA
Xencor XNCR	-73 K	$ 29.2	15.95 %	$ 2.17 B	USA
Annexon ANNX	57 K	$ 3.71	-1.2 %	$ 575 M	USA
Can-Fite BioPharma Ltd. CANF	561 K	$ 1.71	-4.21 %	$ 2.82 M	Israel
Incyte Corporation INCY	25.1 M	$ 113.3	-2.08 %	$ 22.1 B	USA
Mesoblast Limited MESO	21.8 M	$ 12.43	1.22 %	$ 15 B	Australia
MeiraGTx Holdings plc MGTX	12.2 M	$ 9.2	-0.16 %	$ 740 M	USA
Vertex Pharmaceuticals Incorporated VRTX	-7.7 M	$ 516.39	-1.44 %	$ 132 B	USA
Burford Capital Limited BUR	99.1 M	$ 3.24	-3.72 %	$ 710 M	Britain
Catalyst Biosciences CBIO	-1.5 M	$ 12.77	-0.39 %	$ 1.14 B	USA
Amphastar Pharmaceuticals AMPH	23 K	$ 25.47	1.29 %	$ 1.19 B	USA
Editas Medicine EDIT	-2.19 M	$ 2.4	0.05 %	$ 213 M	USA
EyePoint Pharmaceuticals EYPT	11.8 M	$ 0.36	-10.09 %	$ 26.4 K	USA
Fortress Biotech FBIO	17.6 M	$ 1.87	-3.11 %	$ 52.2 M	USA
Fennec Pharmaceuticals FENC	441 K	$ 10.12	0.4 %	$ 289 M	USA
Foghorn Therapeutics FHTX	2.58 M	$ 2.04	2.0 %	$ 128 M	USA
Dr. Reddy's Laboratories Limited RDY	2.83 B	$ 13.76	4.13 %	$ 11.5 B	India
Arcturus Therapeutics Holdings ARCT	10.1 M	$ 9.91	0.71 %	$ 271 M	Israel
Arcutis Biotherapeutics ARQT	443 K	$ 31.74	1.73 %	$ 4.04 B	USA
Geron Corporation GERN	-375 K	$ 1.15	2.23 %	$ 767 M	USA
Gossamer Bio GOSS	9.29 M	$ 9.2	-4.27 %	$ 2.1 B	USA
Titan Pharmaceuticals TTNP	2 K	-	-3.76 %	$ 3.47 M	USA
Allena Pharmaceuticals ALNA	-38 K	-	3.16 %	$ 1.9 M	USA